Market Overview

In most developed nations, the process of taking a new drug to market has become increasingly time consuming and capital intensive. Many companies are faced with the challenge of having to advance their products on a tight schedule and budget. Where can they find more resource to overcome the barriers to commercialization? Crimson believes the solution lies in partnering on a global basis. Asia, and particularly China, has been the fastest growing region in the world. With strong domestic growth, rising income levels, abundant local resources and improving intellectual property rights protection, Crimson sees a new frontier for drug development in China.